InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
T+90 胜率
100%
T+90 平均收益
+46.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Reitan Colleen F, 董事. Insider active across 2 companies, notably Myriad Genetics INC. Cumulatively, 9 filings have been published. Split: 1 buy · 1 sell. Total volume traded: €1.2m. History available since 3 June 2021. The latest transaction was disclosed on 20 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Reitan Colleen F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
671 股0Common StockSEC:0001178670-26-000040:0
18,000 股@ US$100.6599.5% 占其流量Common StockSEC:0001735276-25-000097:0
49,796 股0Common StockSEC:0001628280-25-029973:0
32 股@ US$286.00100.0% 占其流量Common StockSEC:0001735276-25-000062:0
标准退出：2024年11月27日 (T+90)
46,012 股@ US$27.946100.0% 占其流量Common StockSEC:0001628280-24-039405:0
15,695 股0Common StockSEC:0001628280-24-027331:0
15,151 股0Common StockSEC:0001628280-23-020711:0
17,275 股0Common StockSEC:0001628280-22-016217:0
12,848 股0Common StockSEC:0000899243-21-022153:0
9 条申报中的 9 条
About Reitan Colleen F
Colleen F. Reitan is a Board Member at Myriad Genetics Inc. She plays a vital role in overseeing the company's activities and developing strategies aimed at fostering innovation and growth. Her experience in the healthcare sector is beneficial for the organization.
